Should we use combination therapy for all advanced renal cell carcinoma?

Giuseppe Procopio, Pierangela Sepe, Melanie Claps, Filippo de Braud, Elena Verzoni

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)1331-1332
Number of pages2
JournalThe Lancet Oncology
Volume20
Issue number10
DOIs
Publication statusPublished - Oct 2019

ASJC Scopus subject areas

  • Oncology

Cite this

Should we use combination therapy for all advanced renal cell carcinoma? / Procopio, Giuseppe; Sepe, Pierangela; Claps, Melanie; de Braud, Filippo; Verzoni, Elena.

In: The Lancet Oncology, Vol. 20, No. 10, 10.2019, p. 1331-1332.

Research output: Contribution to journalComment/debate

@article{a0cb7710a42e436ca290b01cd800ce44,
title = "Should we use combination therapy for all advanced renal cell carcinoma?",
author = "Giuseppe Procopio and Pierangela Sepe and Melanie Claps and {de Braud}, Filippo and Elena Verzoni",
year = "2019",
month = "10",
doi = "10.1016/S1470-2045(19)30518-2",
language = "English",
volume = "20",
pages = "1331--1332",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "10",

}

TY - JOUR

T1 - Should we use combination therapy for all advanced renal cell carcinoma?

AU - Procopio, Giuseppe

AU - Sepe, Pierangela

AU - Claps, Melanie

AU - de Braud, Filippo

AU - Verzoni, Elena

PY - 2019/10

Y1 - 2019/10

UR - http://www.scopus.com/inward/record.url?scp=85072660099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072660099&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(19)30518-2

DO - 10.1016/S1470-2045(19)30518-2

M3 - Comment/debate

C2 - 31427206

AN - SCOPUS:85072660099

VL - 20

SP - 1331

EP - 1332

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 10

ER -